Tickerplace logo

Tickerplace

Ocular Therapeutix, Inc. logo

OCULOcular Therapeutix, Inc.

OCUL Stock Price, Valuation & Chart | Ocular Therapeutix, Inc.

Compare
$6.500-0.11 (-1.66%)

At close · 23 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

OCUL Historical price chart

OCUL Key Stats

Market Capitalization1.43B
PE Ratio-4.58
EPS-1.42
Trading Volume1.86M
Today's High/Low6.68/6.34
Dividend Yield0.00
52 Week High/Low16.44/6.0
Shares Outstanding219.62M
OCUL Financial Statement
OCUL Analyst ratings
OCUL Analysis & performance metrics

OCUL Company profile

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye…

OCUL Management team

Management
Steve Meyers
Chief Commercial Officer
Peter K. Jarrett Ph.D.
Chief Technical Officer
Todd D.C. Anderman J.D.
Chief Legal Officer & Corporate Secretary
Barry Rubenstein M.S.
Chief Human Resources Officer
Jeffrey S. Heier M.D.
Chief Scientific Officer
Donald Notman Jr.CFO
Chief Financial Officer, Chief Operating Officer & Principal Accounting Officer
William H. Ransone II
Vice President of Global Sales & Marketing
William S. Slattery Jr.
Vice President of Investor Relations
Total 8 executives

OCUL Frequently asked questions

What is Ocular Therapeutix, Inc. (OCUL) Stock Price?

Current stock price of Ocular Therapeutix, Inc. (OCUL) stock is $6.500. The stock price is -1.66% lower in the session. The intraday range can be seen from this page. Volume of Ocular Therapeutix, Inc. (OCUL) stock is 1.86M.

Last updated at 23 Oct 2026, 08:00 pm.

Why is the Ocular Therapeutix, Inc. (OCUL) stock price going up or down today?

The stock price of Ocular Therapeutix, Inc. (OCUL) can change with earnings, company news, and overall market sentiment. Ocular Therapeutix, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ocular Therapeutix, Inc. stock expensive at its current price?

Whether Ocular Therapeutix, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for OCUL on this page is -4.58. EPS on this page is -1.42. Compare those figures with peers and growth expectations before deciding if the current Ocular Therapeutix, Inc. price is justified.

How has the stock price of Ocular Therapeutix, Inc. (OCUL) performed historically?

Historical performance for Ocular Therapeutix, Inc. (OCUL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how OCUL reacted to past earnings and market events.

Should I buy Ocular Therapeutix, Inc. (OCUL) stock, at this price?

Buying Ocular Therapeutix, Inc. (OCUL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.